Design of Chimeric Histone Deacetylase-and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF- …

S Mahboobi, S Dove, A Sellmer, M Winkler…

Index: Mahboobi, Siavosh; Dove, Stefan; Sellmer, Andreas; Winkler, Matthias; Eichhorn, Emerich; Pongratz, Herwig; Ciossek, Thomas; Baer, Thomas; Maier, Thomas; Beckers, Thomas Journal of Medicinal Chemistry, 2009 , vol. 52, # 8 p. 2265 - 2279

Full Text: HTML

Citation Number: 58

Abstract

Inhibitors of histone deacetylases are a new class of cancer therapeutics with possibly broad applicability. Combinations of HDAC inhibitors with the kinase inhibitor 1 (Imatinib) in recent studies showed additive and synergistic effects. Here we present a new concept by combining inhibition of protein kinases and HDACs, two independent pharmacological activities, in one synthetic small molecule. In general, the HDAC inhibition profile, the ...

Related Articles:

Functionalized tetradentate ligands for Ru-sensitized solar cells

[Renouard, Thierry; Graetzel, Michael Tetrahedron, 2001 , vol. 57, # 38 p. 8145 - 8150]

Chemoselective protection of heteroaromatic aldehydes as imidazolidine derivatives: Preparation of 5-substituted furan-and thiophene-2-carboxaldehydes via metallo …

[Carpenter, Andrew J,; Chadwick, Derek J. Tetrahedron, 1985 , vol. 41, # 18 p. 3803 - 3812]

More Articles...